Ganglioneuroma laboratory tests

	Ganglioneuroma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Ganglioneuroma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Ganglioneuroma laboratory tests On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Ganglioneuroma laboratory tests All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Ganglioneuroma laboratory tests
CDC on Ganglioneuroma laboratory tests
Ganglioneuroma laboratory tests in the news
Blogs on Ganglioneuroma laboratory tests
Directions to Hospitals Treating Ganglioneuroma
Risk calculators and risk factors for Ganglioneuroma laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Some patients with ganglioneuroma may have elevated concentrations of VMA (vanillylmandelic acid) or HVA (homovanillic acid) in urine.^[1]^[2]

Some patients with ganglioneuroma may have elevated urinary concentrations of:^[1]^[2]

↑ ^1.0 ^1.1 .Laboratory findings of ganglioneuroma. Carmen Perrino, M.D. & Debra Zynger, M.D. Pathology Outlines. http://www.pathologyoutlines.com/topic/adrenalganglioneuroma.html
↑ ^2.0 ^2.1 Adam, O; Boia, ES (2007). "ganglioneuroma" (PDF). jurnalul pediatrului. 10 (39–40). Retrieved 10 September 2015.